Synartro
Synartro is a Swedish pharmaceutical company developing local injection treatments aiming to provide superior and sustained efficacy without systemic side-effects. This is achieved by combining our patented delivery technology with existing proven drugs. Our pre-clinical lead program focuses on a novel therapy using our compound SYN321 for the treatment of osteoarthritis (OA). Currently this disease leaves up to 50% of patients without adequate pain relief.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Synartro
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- MH
Magnus Hurst
CEO (Acting) · Other
EmailPhone - MN
Maria Nyhage
Board Member · General Business & Management
EmailPhone - MB
Mia Brundin
CEO · General Business & Management
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Synartro
4 distinct titles indexed · top 4 shown.
- 1board member
- 1ceo
- 1ceo (acting)
- 1chief development officer (cdo)
Sign up to unlock all 4 contacts at Synartro
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Synartro
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.